Clinical Trial Update: A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing torcetrapib/atorvastatin versus atorvastatin alone in patients with high triglycerides has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipoproteinemia Type Iv
• Hypertriglyceridemia

Drugs mentioned

• Torcetrapib/atorvastatin (torcetrapib; atorvastatin)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer | Conditions: Hypertriglyceridemia, Hyperlipoproteinemia Type IV | Phase 3 | Status: COMPLETED